Ruiyuan Xu
- Molecular Biology
- Oncology top 10%
- Cancer Research top 10%
- Physiology
- Epidemiology
- Topics
- Pancreatic and Hepatic Oncology Research (14 papers)Epigenetics and DNA Methylation (5 papers)Cancer, Hypoxia, and Metabolism (4 papers)
- Journals
- SHILAP Revista de lepidopterologíaGastroenterologyBiochemical and Biophysical Research Communications
- Partner nations
- China
In The Last Decade
Ruiyuan Xu
23 papers receiving 1.2k citations
Hit Papers
Peers
Comparison fields: 5 of 112
- Molecular Biology 544
- Oncology 324
- Cancer Research 296
- Physiology 176
- Epidemiology 141
Countries citing papers authored by Ruiyuan Xu
This map shows the geographic impact of Ruiyuan Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruiyuan Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruiyuan Xu more than expected).
Fields of papers citing papers by Ruiyuan Xu
This network shows the impact of papers produced by Ruiyuan Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruiyuan Xu. The network helps show where Ruiyuan Xu may publish in the future.
Co-authorship network of co-authors of Ruiyuan Xu
This figure shows the co-authorship network connecting the top 25 collaborators of Ruiyuan Xu. A scholar is included among the top collaborators of Ruiyuan Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruiyuan Xu. Ruiyuan Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 11 | |
| 2 | 8 | |
| 3 | 3 | |
| 4 | Obesity and type 2 diabetes mellitus: connections in epidemiology, pathogenesis, and treatmentsbreakdown → | 351 |
| 5 | 48 | |
| 6 | 43 | |
| 7 | 14 | |
| 8 | 73 | |
| 9 | 13 | |
| 10 | 3 | |
| 11 | 36 | |
| 12 | 18 | |
| 13 | Early screening and diagnosis strategies of pancreatic cancer: a comprehensive reviewbreakdown → | 214 |
| 14 | 8 | |
| 15 | 32 | |
| 16 | 95 | |
| 17 | 54 | |
| 18 | 32 | |
| 19 | 72 | |
| 20 | 13 |
About Ruiyuan Xu
Ruiyuan Xu is a scholar working on Oncology, Cancer Research and Toxicology, having authored 23 papers that have together received 1.2k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (14 papers), Epigenetics and DNA Methylation (5 papers) and Cancer, Hypoxia, and Metabolism (4 papers). The work is most often cited by research in Cancer Research (296 citations), Oncology (324 citations) and Endocrinology, Diabetes and Metabolism (134 citations). Ruiyuan Xu has collaborated with scholars based in China. Frequent co-authors include Jianlu Song, Rexiati Ruze, Xinpeng Yin, Lei You, Jinshou Yang, Bo Ren, Yupei Zhao, Chengcheng Wang, Yuan Chen and Qiang Xu. Their work appears in journals such as SHILAP Revista de lepidopterología, Gastroenterology and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.